发明授权
- 专利标题： HEPATITIS C VIRUS INHIBITORS
- 专利标题（中）： 丙型肝炎病毒抑制剂
-
申请号： EP07813923.5申请日： 2007-08-09
-
公开(公告)号： EP2049116B1公开(公告)日： 2012-02-29
- 发明人: BACHAND, Carol , BELEMA, Makonen , DEON, Daniel H. , GOOD, Andrew C. , GOODRICH, Jason , JAMES, Clint A. , LAVOIE, Rico , LOPEZ, Omar D. , MARTEL, Alain , MEANWELL, Nicholas A. , NGUYEN, Van N. , ROMINE, Jeffrey Lee , RUEDIGER, Edward H. , SNYDER, Lawrence B. , ST. LAURENT, Denis R. , YANG, Fukang , LANGLEY, David R. , HAMANN, Lawrence G.
- 申请人： Bristol-Myers Squibb Company
- 申请人地址： Route 206 and Province Line Road Princeton, NJ 08543-4000 US
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： Route 206 and Province Line Road Princeton, NJ 08543-4000 US
- 代理机构： Reitstötter - Kinzebach
- 优先权： US836999P 20060811
- 国际公布： WO2008021928 20080221
- 主分类号： A61K31/506
- IPC分类号： A61K31/506 ; A61K31/501 ; A61K31/497 ; A61K31/444 ; A61K31/4439 ; A61P31/12 ; C07D401/14 ; C07D403/14
摘要：
The present disclosure relates to compounds of formula (I), or a pharmaceutically acceptable salt thereof, wherein A and B are selected from phenyl and a six-membered heteroaromatic ring containing one, two or three nitrogen atoms; provided that at least one of A and B is other than phenyl, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
公开/授权文献
- EP2049116A2 HEPATITIS C VIRUS INHIBITORS 公开/授权日：2009-04-22
信息查询
IPC分类:
